Previous 10 | Next 10 |
home / stock / mgclf / mgclf news
(NewsDirect) MGC Pharmaceuticals chief commercial officer Robert Clements joined Proactive's Stephen Gunnion with details of the company's activity in the first quarter of 2023, as well as upcoming milestones. Clements noted that clinical trials of its CimetrA drug continue to demonst...
2023-04-11 06:39:42 ET MGC Pharmaceuticals ( OTCPK:MGCLF ) said its epilepsy product CannEpil is now available to patients in the U.K. via Named Patient Request. The company noted that CannEpil is an investigational medicinal product (IMP) for patients with refractory ep...
MGC Pharma's CannEpil® Now Accessible to UK Patients on Named Patient Request Basis PR Newswire European pharmaceutical company offers its investigational medicinal product to a wide range of specialist medical practitioners in the United Kingdom Epidiolex's S...
(NewsDirect) MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive after announcing that the company has been granted permission by the Slovenian government to conduct research into psilocybin, a naturally occurring psychedelic ...
(NewsDirect) MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner after announcing the enrolment of the first patient in its proprietary data collection App and machine learning algorithm, ZAM. Clements expl...
ArtemiC TM Listed as an OTC Drug in the USA; AMC Places US$2m Order PR Newswire Innovative Plant-Based Medicine Set to Transform Inflammatory Disease Treatments in the US Market LONDON , March 22, 2023 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX...
(NewsDirect) MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief medical officer Nadya Lisovoder speaks to Proactive's Thomas Warner after announcing the completion of an in-vitro pre-clinical mechanism of action (MoA) study for the European based bio-pharma company's CimetrA plat...
(NewsDirect) MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner about how the business performed during the fourth quarter of 2022. Clements says that the "numbers were very good" and reveals more details about ho...
MGC Pharmaceuticals (OTCPK:MGCLF) signed an exclusive distribution agreement with Sciensus Rare for distributing phytocannabinoid derived products — CannEpil to treat drug resistant epilepsy and CogniCann for Dementia and Alzheimer's disease — in certain European terri...
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK PR Newswire LONDON , April 5, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC, A...
News, Short Squeeze, Breakout and More Instantly...
MGC Pharmaceuticals Ltd Company Name:
MGCLF Stock Symbol:
OTCMKTS Market:
--News Direct-- Argent BioPharma managing director and CEO Roby Zomer speaks to Proactive's Stephen Gunnion following the company's rebranding from MGC Pharmaceuticals, alongside a comprehensive restructuring. Zomer explained the shift marks a refined focus on the pharmaceutical s...
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation PR Newswire Embracing Comprehensive Restructuring for a New Biopharmaceutical Era Continuing the Development of MGC Pharma's Innovative Drug Portfolio LONDON , Feb. 13, 2024 /PRNe...
(NewsDirect) MGC Pharmaceuticals Ltd CEO and Managing Director Roby Zomer speaks to Thomas Warner from Proactive London following the completion of a share consolidation and capital raise. With these restructuring initiatives completed, Zomer shares his enthusiasm for the future of th...